(2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

C34H32F3N5O6 — CID 122531401

IUPAC(2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2ccc(C(C)=O)cc2)c2ccccc2N(Cc2c(OCC(F)(F)F)c[n+]([O-])c3ccccc23)C1=O
InChIInChI=1S/C34H32F3N5O6/c1-20(38-3)31(44)39-26-17-41(32(45)23-14-12-22(13-15-23)21(2)43)29-11-7-6-10-28(29)40(33(26)46)16-25-24-8-4-5-9-27(24)42(47)18-30(25)48-19-34(35,36)37/h4-15,18,20,26,38H,16-17,19H2,1-3H3,(H,39,44)/t20-,26-/m0/s1
InChIKeyNAPUAFOAUICUGC-FNZWTVRRSA-N
MW663.65 g/mol
LogP3.90
Rot. Bonds9

About (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

(2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (PubChem CID 122531401) has the molecular formula C34H32F3N5O6 and a molecular weight of 663.65 g/mol. Its IUPAC name is (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.

Molecular Properties

Compound Name(2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
PubChem CID122531401
Molecular FormulaC34H32F3N5O6
Molecular Weight663.65 g/mol
Exact Mass663.23
IUPAC Name(2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2ccc(C(C)=O)cc2)c2ccccc2N(Cc2c(OCC(F)(F)F)c[n+]([O-])c3ccccc23)C1=O
InChIInChI=1S/C34H32F3N5O6/c1-20(38-3)31(44)39-26-17-41(32(45)23-14-12-22(13-15-23)21(2)43)29-11-7-6-10-28(29)40(33(26)46)16-25-24-8-4-5-9-27(24)42(47)18-30(25)48-19-34(35,36)37/h4-15,18,20,26,38H,16-17,19H2,1-3H3,(H,39,44)/t20-,26-/m0/s1
InChIKeyNAPUAFOAUICUGC-FNZWTVRRSA-N
XLogP3.90
TPSA134.99 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms48
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500663.65
LogP ≤ 53.90
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het_pyridiniums_A(39)', 'substructure': 'N/A'}, {'alert_name': 'N_oxide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The IUPAC name of (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (CID 122531401) is (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.
What is the SMILES notation for (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The canonical SMILES for (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)c2ccc(C(C)=O)cc2)c2ccccc2N(Cc2c(OCC(F)(F)F)c[n+]([O-])c3ccccc23)C1=O.
What is the InChIKey of (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The InChIKey is NAPUAFOAUICUGC-FNZWTVRRSA-N. The full InChI is InChI=1S/C34H32F3N5O6/c1-20(38-3)31(44)39-26-17-41(32(45)23-14-12-22(13-15-23)21(2)43)29-11-7-6-10-28(29)40(33(26)46)16-25-24-8-4-5-9-27(24)42(47)18-30(25)48-19-34(35,36)37/h4-15,18,20,26,38H,16-17,19H2,1-3H3,(H,39,44)/t20-,26-/m0/s1.
What are the key properties of (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
(2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide has a molecular weight of 663.65 g/mol, XLogP of 3.90, 9 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(3S)-1-(4-acetylbenzoyl)-5-[[1-oxido-3-(2,2,2-trifluoroethoxy)quinolin-1-ium-4-yl]methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is sourced from PubChem (CID 122531401), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).